CD8A and neoplasm: Inversely, LXRα/β inhibition was reported to induce tumor elimination in TNBC via enhancement of CD8+ T-cell cytotoxicity, mitochondrial metabolism activity, restoration of cytotoxic T-cell clonal expansion and plasma membrane localization (Carpenter et al., 2019).